Federal Register / Vol. 75, No. 43 / Friday, March 5, 2010 / Notices 10311 

managing the habitat to promote 

persistence of the butterfly, and the 

assurances they have received under the 

current conservation program would 

cease. Landowners who wish to 

proactively conserve their land to 

promote recovery of the butterfly in 

Wisconsin would need their own 

permits under Section 10, with an HCP 

or Safe Harbor Agreement for their 

lands. 

Reviewing Documents and Submitting 

Comments 

Please refer to TE010064 when 

requesting documents or submitting 

comments. The permit application and 

supporting documents (updated draft 

HCP and draft EA) may be obtained on 

the Internet at the following address: 

http://www.fws.gov/midwest/ 

endangered/permits/hcp/r3hcps.html. 

In addition, the original HCP, dated 

March 2000, may be viewed on the 

Wisconsin DNR Web site at http:// 

dnr.wi.gov/forestry/karner/. Persons 

without access to the Internet may 

obtain copies of the documents 

(application, updated draft HCP, and 

draft EA) by contacting the U.S. Fish 

and Wildlife Service, Ecological 

Services Field Office, 2661 Scott Tower 

Drive, New Franken, WI 54229–9565 

(920/866–1717, voice; 920/866–1710, 

fax). The documents will also be 

available for public inspection, by 

appointment, during normal business 

hours (8 a.m. to 4:30 p.m.) at the 

Ecological Services Field Office in New 

Franken and at the Service’s Regional 

Office, Ecological Services, Bishop 

Henry Whipple Federal Building, 1 

Federal Drive, 6th Floor, Ft. Snelling, 

MN 55111 (612/713–5164, voice; 612/ 

713–5292, fax). Written comments will 

be accepted as described above. 

Public Availability of Comments 

Written comments we receive become 

part of the public record associated with 

this action. Before including your 

address, phone number, e-mail address, 

or other personal identifying 

information in your comment, you 

should be aware that the entire 

comment, including your personal 

identifying information, may be made 

available at any time. While you can ask 

us in your comment to withhold your 

personal identifying information from 

public review, we cannot guarantee that 

we will be able to do so. 

Authority : We provide this notice under 

section 10(c) of the Act (16 U.S.C. 1531 et 

seq.) and its implementing regulations (50 

CFR 17.22), and NEPA (42 U.S.C. 4371 et 

seq.) and its implementing regulations (40 

CFR 1506.6). 

T.J. Miller, 

Acting, Assistant Regional Director, 

Ecological Services, Region 3, Fort Snelling, 

Minnesota. 

[FR Doc. 2010–4708 Filed 3–4–10; 8:45 am] 

BILLING CODE 4310–55–P 

INTERNATIONAL TRADE 

COMMISSION 

[Inv. No. 337–TA–631] 

In the Matter of Certain Liquid Crystal 

Display Devices and Products 

Containing the Same; Notice of 

Commission Determination To Rescind 

a Limited Exclusion Order and Cease 

and Desist Orders 

AGENCY: U.S. International Trade 

Commission. 

ACTION: Notice. 

SUMMARY: Notice is hereby given that 

the U.S. International Trade 

Commission has determined to rescind 

the limited exclusion order and cease 

and desist orders issued in the abovecaptioned investigation. 

FOR FURTHER INFORMATION CONTACT: 

Clint A. Gerdine, Office of the General 

Counsel, U.S. International Trade 

Commission, 500 E Street, SW., 

Washington, DC 20436, telephone (202) 

708–2310. Copies of non-confidential 

documents filed in connection with this 

investigation are or will be available for 

inspection during official business 

hours (8:45 a.m. to 5:15 p.m.) in the 

Office of the Secretary, U.S. 

International Trade Commission, 500 E 

Street, SW., Washington, DC 20436, 

telephone (202) 205–2000. General 

information concerning the Commission 

may also be obtained by accessing its 

Internet server (http://www.usitc.gov). 

The public record for this investigation 

may be viewed on the Commission’s 

electronic docket (EDIS) at http:// 

edis.usitc.gov. Hearing-impaired 

persons are advised that information on 

this matter can be obtained by 

contacting the Commission’s TDD 

terminal on (202) 205–1810. 

SUPPLEMENTARY INFORMATION: The 

Commission instituted this investigation 

on January 25, 2008, based on a 

complaint filed by Samsung Electronics 

Co., Ltd. (‘‘Samsung’’) of Korea. 73 FR 

4626–27. The complaint, as 

supplemented, alleged violations of 

section 337 of the Tariff Act of 1930, as 

amended, 19 U.S.C. **1337, in the 

importation into the United States, the 

sale for importation, and the sale within 

the United States after importation of 

certain liquid crystal display (‘‘LCD’’) 

devices and products containing the 

same by reason of infringement of 

certain claims of U.S. Patent Nos. 

7,193,666; 6,771,344 (‘‘the ‘344 patent’’); 

7,295,196; and 6,937,311 (‘‘the ‘311 

patent’’). The complaint further alleged 

the existence of a domestic industry as 

to each asserted patent. The 

Commission’s notice of investigation 

named the following respondents: Sharp 

Corporation of Japan; Sharp Electronics 

Corporation of Mahwah, New Jersey; 

and Sharp Electronics Manufacturing 

Company of America, Inc. of San Diego, 

California (collectively, ‘‘Sharp’’). 

On January 26, 2009, the presiding 

administrative law judge (‘‘ALJ’’) issued 

his final initial determination (‘‘ID’’) 

finding a violation of section 337 by 

respondents as to the ‘311 and ‘344 

patents only, and issued his 

recommended determinations on 

remedy and bonding. On February 9, 

2009, Sharp and the Commission 

investigative attorney (‘‘IA’’) filed 

petitions for review of the final ID. The 

IA and Samsung filed responses to the 

petitions on February 17, 2009. 

On March 30, 2009, the Commission 

determined to review several of the ID’s 

findings, and requested the parties to 

respond to certain questions concerning 

those findings. The Commission also 

requested written submissions on the 

issues of remedy, the public interest, 

and bonding from the parties and 

interested non-parties. 74 FR 15301–02 

(April 3, 2009). 

On April 10 and April 17, 2009, 

respectively, complainant Samsung, the 

Sharp respondents, and the IA filed 

briefs and reply briefs on the issues for 

which the Commission requested 

written submissions. Also, the 

Commission received four submissions 

from interested non-parties on the 

issues of remedy, the public interest, 

and bonding. 

On June 24, 2009, the Commission 

issued notice of its determination to 

affirm-in-part and reverse-in-part the ID. 

The Commission affirmed the ALJ’s 

finding of a violation of section 337 

with respect to claims 7 and 8 of the 

‘344 patent, but reversed the ALJ’s 

finding of a violation with respect to the 

‘311 patent. 74 FR 31311–12 (June 30, 

2009) 

Further, the Commission issued (as 

modified on December 14, 2009): (1) A 

limited exclusion order prohibiting the 

unlicensed entry of LCD devices, 

including display panels and modules, 

and LCD televisions or professional 

displays containing the same that 

infringe claims 7 or 8 of the ‘344 patent, 

that are manufactured abroad by or on 

behalf of, or are imported by or on 


erowe on DSK5CLS3C1PROD with NOTICES
10312 Federal Register / Vol. 75, No. 43 / Friday, March 5, 2010 / Notices 

behalf of, Sharp, or any of its affiliated 

companies, parents, subsidiaries, 

licensees, contractors, or other related 

business entities, or successors or 

assigns; and (2) cease and desist orders 

prohibiting Sharp Electronics Corp. and 

Sharp Electronics Manufacturing Co. 

from conducting any of the following 

activities in the United States: 

Importing, selling, marketing, 

advertising, distributing, offering for 

sale, transferring (except for 

exportation), and soliciting U.S. agents 

or distributors for, LCD devices, 

including display panels and modules, 

and LCD televisions or professional 

displays containing the same that are 

covered by claims 7 or 8 of the ‘344 

patent. 

On February 12, 2010, complainant 

Samsung and respondent Sharp filed a 

joint petition to rescind the remedial 

orders under Commission Rule 

210.76(a)(1) on the basis of a settlement 

agreement between the parties. The 

parties asserted that their settlement 

agreement constitutes ‘‘changed 

conditions of fact or law’’ sufficient to 

justify rescission of the order under 

Commission Rule 210.76(a)(1), 19 CFR 

210.76(a)(1). The IA did not oppose the 

joint petition. 

Having reviewed the parties’ 

submissions, the Commission has 

determined that the settlement 

agreement satisfies the requirement of 

Commission Rule 210.76(a)(1), 19 CFR 

210.76(a)(1), that there be changed 

conditions of fact or law. The 

Commission therefore has issued an 

order rescinding the limited exclusion 

order and cease and desist orders 

previously issued in this investigation. 

This action is taken under the 

authority of section 337 of the Tariff Act 

of 1930 (19 U.S.C. 1337) and section 

210.76(a)(1) of the Commission’s Rules 

of Practice and Procedure (19 CFR 

210.76(a)(1)). 

Issued: March 1, 2010. 

By order of the Commission. 

Marilyn R. Abbott, 

Secretary to the Commission. 

[FR Doc. 2010–4692 Filed 3–4–10; 8:45 am] 

BILLING CODE 7020–02–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Importer of Controlled Substances; 

Notice of Registration 

By Notice dated October 20, 2009, and 

published in the Federal Register on 

October 28, 2009 (74 FR 55583), 

Formulation Technologies LLC., 11501 

Domain Drive, Suite 130, Austin, Texas 

78758, made application by renewal to 

the Drug Enforcement Administration 

(DEA) to be registered as an importer of 

Fentanyl (9801), a basic class of 

controlled substance listed in schedule 

II. 

The company plans to import the 

listed controlled substance for analytical 

characterization, secondary packaging, 

and for distribution to clinical trial sites. 

No comments or objections have been 

received. DEA has considered the 

factors in 21 U.S.C. 823(a) and 952(a), 

and determined that the registration of 

Formulation Technologies LLC., to 

import the basic class of controlled 

substance is consistent with the public 

interest, and with United States 

obligations under international treaties, 

conventions, or protocols in effect on 

May 1, 1971, at this time. DEA has 

investigated Formulation Technologies 

LLC., to ensure that the company’s 

registration is consistent with the public 

interest. The investigation has included 

inspection and testing of the company’s 

physical security systems, verification 

of the company’s compliance with state 

and local laws, and a review of the 

company’s background and history. 

Therefore, pursuant to 21 U.S.C. 952(a) 

and 958(a), and in accordance with 21 

CFR 1301.34, the above named company 

is granted registration as an importer of 

the basic class of controlled substance 

listed. 

Dated: February 26, 2010. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration. 

[FR Doc. 2010–4722 Filed 3–4–10; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Importer of Controlled Substances 

Notice of Registration 

By Notice dated November 23, 2009, 

and published in the Federal Register 

on December 2, 2009 (74 FR 63155), 

Cambrex Charles City, Inc., 1205 11th 

Street, Charles City, Iowa 50616, made 

application by renewal to the Drug 

Enforcement Administration (DEA) to 

be registered as an importer of the basic 

classes of controlled substances listed in 

schedule II: 

Drug Schedule 

Opium, raw (9600) ....................... II 

Poppy Straw Concentrate (9670) II 

The company plans to import the 

basic classes of controlled substances 

for manufacture of active 

pharmaceutical ingredients for sale to 

its customers. 

No comments or objections have been 

received. DEA has considered the 

factors in 21 U.S.C. 823(a) and 952(a), 

and determined that the registration of 

Cambrex Charles City, Inc. to import the 

basic classes of controlled substances is 

consistent with the public interest, and 

with United States obligations under 

international treaties, conventions, or 

protocols in effect on May 1, 1971, at 

this time. DEA has investigated 

Cambrex Charles City, Inc. to ensure 

that the company’s registration is 

consistent with the public interest. The 

investigation has included inspection 

and testing of the company’s physical 

security systems, verification of the 

company’s compliance with state and 

local laws, and a review of the 

company’s background and history. 

Therefore, pursuant to 21 U.S.C. 952(a) 

and 958(a), and in accordance with 21 

CFR 1301.34, the above named company 

is granted registration as an importer of 

the basic classes of controlled 

substances listed. 

Dated: February 26, 2010. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration. 

[FR Doc. 2010–4773 Filed 3–4–10; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Importer of Controlled Substances 

Notice of Registration 

By Notice dated October 21, 2009, and 

published in the Federal Register on 

October 28, 2009 (74 FR 55584), Hospira 

Inc., 1776 North Centennial Drive, 

McPherson, Kansas 67460–1247, made 

application by renewal to the Drug 

Enforcement Administration (DEA) to 

be registered as an importer of 

Remifentanil (9739), a basic class of 

controlled substance listed in schedule 

II. 

The company plans to import 

Remifentanil for use in dosage form 

manufacturing. 

No comments or objections have been 

received. DEA has considered the 

factors in 21 U.S.C. 823(a) and 952(a), 

and determined that the registration of 

Hospira Inc. to import the basic class of 

controlled substance is consistent with 

the public interest, and with United 

States obligations under international 


erowe on DSK5CLS3C1PROD with NOTICES